Top

BMC Musculoskeletal Disorders

Published in:

Open Access 01-12-2015 | Research article

Surgical treatment of tumor-induced osteomalacia: a retrospective review of 40 cases with extremity tumors

Authors: Zhi-jian Sun, Jin Jin, Gui-xing Qiu, Peng Gao, Yong Liu

Published in: BMC Musculoskeletal Disorders | Issue 1/2015

Abstract

Background

Tumor-induced osteomalacia (TIO) is a rare syndrome typically caused by mesenchymal tumors. It has been shown that complete tumor resection may be curative. However, to our knowledge, there has been no report of a large cohort to exam different surgical approaches. This study was aimed to assess outcomes of different surgical options of patients with tumor-induced osteomalacia at a single institution.

Methods

Patients with extremity tumors treated in our hospital from January, 2004 to July, 2012 were identified. The minimum follow-up period was 12 months. Patient’s demography, tumor location, preoperative preparation, type of surgeries were summarized, and clinical outcomes were recorded. Successful treatment was defined as significant symptom improvement, normal serum phosphorus and significant improvement or normalization of bone mineral density at the last follow-up. Differences between patients with soft tissue tumors and bone tumors were compared.

Results

There were 40 (24 male and 16 female) patients identified, with an average age of 44 years. The tumors were isolated in either soft tissue (25 patients) or bone (12 patients) and combined soft tissue and bone invasion was observed in 3 patients. For the primary surgery, tumor resection and tumor curettage were performed. After initial surgical treatment, six patients then received a second surgery. Four patients were found to have malignant tumors base on histopathology. With a minimum follow-up period of 12 months, 80% of patients (32/40) were treated successfully, including 50% of patients (2/4) with malignant tumors. Compared to patients with bone tumor, surgical results were better in patient with soft tissue tumor.

Conclusions

Surgical treatment was an effective way for TIO. Other than tumor curettage surgery, tumor resection is the preferred options for these tumors.

Drezner MK. Tumor-induced osteomalacia. Rev Endocr Metab Disord. 2001;2:175–86.CrossRefPubMed

Chong WH, Molinolo AA, Chen CC, Collins MT. Tumor-induced osteomalacia. Endocr Relat Cancer. 2011;18:R53–77.CrossRefPubMedPubMedCentral

Econs MJ, Drezner MK. Tumor-induced osteomalacia–unveiling a new hormone. N Engl J Med. 1994;330:1679–81.CrossRefPubMed

Juppner H, Wolf M, Salusky IB. FGF-23: More than a regulator of renal phosphate handling? J Bone Miner Res. 2010;25:2091–7.CrossRefPubMedPubMedCentral

Berndt T, Craig TA, Bowe AE, Vassiliadis J, Reczek D, Finnegan R, et al. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J Clin Invest. 2003;112:785–94.CrossRefPubMedPubMedCentral

Quarles LD. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab. 2003;285:E1–9.CrossRefPubMed

Carpenter TO, Ellis BK, Insogna KL, Philbrick WM, Sterpka J, Shimkets R. Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors. J Clin Endocrinol Metab. 2005;90:1012–20.CrossRefPubMed

De Beur SM, Finnegan RB, Vassiliadis J, Cook B, Barberio D, Estes S, et al. Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J Bone Miner Res. 2002;17:1102–10.CrossRefPubMed

Duet M, Kerkeni S, Sfar R, Bazille C, Liote F, Orcel P. Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia. Clin Nucl Med. 2008;33:752–6.CrossRefPubMed

10.

Khadgawat R, Singh Y, Kansara S, Tandon N, Bal C, Seith A, et al. PET/CT localisation of a scapular haemangiopericytoma with tumour-induced osteomalacia. Singapore Med J. 2009;50:e55–7.PubMed

11.

Andreopoulou P, Dumitrescu CE, Kelly MH, Brillante BA, Cutler PC, Wodajo FM, et al. Selective venous catheterization for the localization of phosphaturic mesenchymal tumors. J Bone Miner Res. 2011;26:1295–302.CrossRefPubMed

12.

Ito N, Shimizu Y, Suzuki H, Saito T, Okamoto T, Hori M, et al. Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia. J Intern Med. 2010;268:390–4.CrossRefPubMed

13.

Jiang Y, Xia WB, Xing XP, Silva BC, Li M, Wang O, et al. Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature. J Bone Miner Res. 2012;27:1967–75.CrossRefPubMed

14.

Khaliq W, Cheripalli P, Tangella K. Tumor-induced osteomalacia (TIO): atypical presentation. South Med J. 2011;104:348–50.CrossRefPubMed

15.

Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004;28:1–30.CrossRefPubMed

16.

Harbeck B, Schocklmann H, Seekamp A, Czech N, Monig H. Tumor-induced osteomalacia: successful treatment by radio-guided tumor surgery. J Clin Rheumatol. 2009;15:31–4.CrossRefPubMed

17.

Hesse E, Rosenthal H, Bastian L. Radiofrequency ablation of a tumor causing oncogenic osteomalacia. N Engl J Med. 2007;357:422–4.CrossRefPubMed

18.

Tutton S, Olson E, King D, Shaker JL. Successful Treatment of Tumor-Induced Osteomalacia with CT-Guided Percutaneous Ethanol and Cryoablation. J Clin Endocrinol Metab. 2012;97:3421–5.CrossRefPubMed

19.

Fuentealba C, Pinto D, Ballesteros F, Pacheco D, Boettiger O, Soto N, et al. Oncogenic hypophosphatemic osteomalacia associated with a nasal hemangiopericytoma. J Clin Rheumatol. 2003;9:373–9.CrossRefPubMed

20.

Uramoto N, Furukawa M, Yoshizaki T. Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue. Auris Nasus Larynx. 2009;36:104–5.CrossRefPubMed

21.

Sidell D, Lai C, Bhuta S, Barnes L, Chhetri DK. Malignant phosphaturic mesenchymal tumor of the larynx. Laryngoscope. 2011;121:1860–3.CrossRefPubMed

Title: Surgical treatment of tumor-induced osteomalacia: a retrospective review of 40 cases with extremity tumors
Authors: Zhi-jian Sun
Jin Jin
Gui-xing Qiu
Peng Gao
Yong Liu
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: BMC Musculoskeletal Disorders / Issue 1/2015
Electronic ISSN: 1471-2474
DOI: https://doi.org/10.1186/s12891-015-0496-3

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Surgical treatment of tumor-induced osteomalacia: a retrospective review of 40 cases with extremity tumors

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2015

Cervical cage without plating in management of type II / II A Hangman’s fracture combined with intervertebral disc injury

The effect of three-dimensional computed tomography reconstructions on preoperative planning of tibial plateau fractures: a case–control series

Work related etiology of de Quervain’s tenosynovitis: a case-control study with prospectively collected data

The motherhood choices decision aid for women with rheumatoid arthritis increases knowledge and reduces decisional conflict: a randomized controlled trial

Erratum: Sagittal plane gait characteristics in hip osteoarthritis patients with mild to moderate symptoms compared to healthy controls: a cross-sectional study

The Brazilian Portuguese version of the revised Maastricht Upper Extremity Questionnaire (MUEQ-Br revised): translation, cross-cultural adaptation, reliability, and structural validation